Publication | Open Access
The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer
57
Citations
48
References
2014
Year
We show that <i>BRCA1</i> PM is common in TNBC and has the potential to identify a significant fraction of TNBC patients who have suboptimal outcomes with standard chemotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1